Inhibrx, Inc. Employee Directory
Biotechnology ResearchCalifornia, United States51-200 Employees
Inhibrx Biosciences, Inc. is a biotechnology research company headquartered at 11025 North Torrey Pines Road Suite 140, La Jolla, California 92037, United States. The company operates in the biotechnology research industry and has between 51 and 200 employees. It focuses on developing biologic therapeutics for life-threatening conditions, particularly cancer and orphan diseases, using a single domain antibody platform. The sdAb platform enables multivalent and multispecific therapeutic formats designed to cluster receptors, engage multiple antigens or epitopes, combine synergistic functions, and restrict activity to tumor tissue or other distinct biological environments. In January 2024, Sanofi announced acquisition of Inhibrx in a transaction valued at up to $2.2 billion; the company reports revenue in the range of $1–$10 million and has raised about $150 million in funding.